February 08, 2018
A reference laboratory can't sue Protagonist Therapeutics for allegedly infringing a patent tied to a potential treatment for autoimmune disorders, as the drug company is protected by a safe harbor tied to developing drugs to be submitted for federal approval, a California federal judge said Wednesday in dismissing the suit.
January 19, 2018
A California federal judge told Medical Diagnostic Laboratories LLC on Friday that he may have to dismiss its patent infringement suit over its proprietary peptides because they were allegedly used by Protagonist Therapeutics Inc. to develop an autoimmune disorder drug for U.S. Food and Drug Administration approval, an activity protected by the safe harbor rule.